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ABSTRACT
The target-derived factors necessary for promoting
initial outgrowth from the statoacoustic ganglion
(SAG) to the inner ear have not been fully charac-
terized. In the present study, conditioned medium
from embryonic Immortomouse inner ear cell lines
that maintain many characteristics of developing
inner ear sensory epithelia were screened for neu-
rite-promoting activity. Conditioned medium found
to be positive for promoting SAG neurite outgrowth
and neuronal survival was then tested for the
presence of chemokines, molecules that have not
previously been investigated for promoting SAG
outgrowth. One candidate molecule, monocyte che-
motactic protein 1 (MCP-1), was detected in the con-
ditioned medium and subsequently localized to
mouse hair cells by immunocytochemistry. In vitro
studies demonstrated that function-blocking MCP-1
antibodies decreased the amount of SAG neurite
outgrowth induced by the conditioned medium and
that subsequent addition of MCP-1 protein was able
to promote outgrowth when added to the antibody-
treated conditioned medium. The use of the Immor-
tomouse cell lines proved valuable in identifying this
candidate cofactor that promotes outgrowth of early-
stage SAG nerve fibers and is expressed in embryonic
hair cells.
Keywords: auditory, cochlea, neural, development,
spiral ganglion, Immortomouse
INTRODUCTION
Inner-ear-derived growth factors. Target-derived growth
and survival factors are critically important for the
development of neuronal populations. Such factors
also appear to regulate innervation of the developing
inner ear at the otocyst stage (reviewed by Barald and
Kelley 2004). During early stages of embryogenesis
[embryonic day (E) 4–6 chick; E11–14 mouse, rat],
the otocyst releases (a) soluble factor(s) that pro-
mote the outgrowth and survival of innervating
statoacoustic ganglion (SAG) neurons (Ard and
Morest 1984; Ard et al. 1985; Lefebvre et al. 1990;
Bianchi and Cohan 1991, 1993a). The otocyst-derived
factors (ODF) from chick, mouse, and rat have
similar bioactivity, and each can promote outgrowth
from the other species. For example, cultured E12–
14 mouse inner ears secrete ODF that promotes
outgrowth of E4–6 chick SAG, and cultured E4–6
chick inner ears secrete ODF that promotes out-
growth of E12–14 mouse SAG (Bianchi and Cohan
1993a). Thus, ODF refers to the factor(s) released
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from the early-stage otocyst of any of these species.
The identities of the biologically active components
of ODF, which appear to be critical during early
stages of neurite outgrowth, have not been fully
characterized.
In contrast to the initial stages of neurite out-
growth, as the SAG ultimately separates to form the
distinct cochlear and vestibular ganglia, each of these
neural populations begins to rely on specific, identi-
fied growth factors. Beginning at the time of synapto-
genesis (approximately E13.5, in mouse), the majority
of cochlear neurons becomes dependent on neuro-
trophin-3 for survival, whereas vestibular neurons rely
primarily on brain-derived neurotrophic factor
(BDNF) (reviewed by Fritzsch et al. 1997). However,
prior to this period, when afferent fibers are first
extending toward the target cells in the periphery,
these neurotrophins alone are not sufficient for the
survival or outgrowth of SAG neurons (Bianchi and
Cohan 1993a; Bianchi et al. 1998; Tessarollo et al.
2004). Other studies have also suggested that FGFs
and BDNF play a sequential role in regulating aspects
of SAG migration, differentiation, and outgrowth
(Hossain et al. 1997; Brumwell et al. 2000).
Previous studies compared ODF to other growth
factors in an attempt to identify the active components
of ODF. Comparisons with a large number of growth
factors including the neurotrophins, ciliary neuro-
trophic factor (CNTF), fibroblast growth factors
(FGFs), transforming growth factors (TGFs) and
tumor necrosis factors (TNFs) failed to identify a
candidate molecule for ODF (Bianchi and Cohan
1993a,b). Although these assays did not indicate that
FGFs alone mimicked ODF, other laboratories have
reported a role for FGFs in regulating aspects of SAG
neuroblast migration and neurite outgrowth (Hossain
and Morest 2000). In our assays, only CNTF promot-
ed neurite outgrowth of SAG explants similar to that
observed with chick ODF-conditioned medium. How-
ever, CNTF had no effect on survival or outgrowth of
dissociated SAG neurons, suggesting that its effect on
explants was indirect, perhaps through interactions
with the nonneuronal cells present in the ganglion
explant (Bianchi and Cohan 1993a). Furthermore,
ODF did not demonstrate any CNTF-like bioactivity
(Bianchi and Cohan 1993a; Bianchi et al. 1998).
A cytokine or chemokine other than CNTF may
normally influence SAG outgrowth in vivo. Chemo-
kine proteins were initially identified for their ability
to attract and activate immune cells by interacting
with specific receptors (Coughlan et al. 2000). Recent
studies have demonstrated that chemokines are also
present in developing neurons and have suggested
that these molecules may also play roles in neuronal
migration, outgrowth, or survival (Meng et al. 1999;
Chalasani et al. 2003a,b; Belmandi et al. 2005). In
some cases, the chemokines were found to regulate
axonal outgrowth by inhibiting the repellent effects of
molecules such as semaphorins and slit-2 (Chalasani
et al. 2003b). This is the first report documenting
the expression and function of chemokines in the
developing inner ear.
Sources of SAG neurite-promoting factors. Due to the
small size of the otocyst it is difficult to generate
sufficient quantities of otocyst-conditioned medium
for biochemical analysis from the organ itself. Thus,
another tissue source is needed. Earlier studies found
that conditioned medium from tissues such as limb
bud and heart did not contain SAG neurite-promot-
ing factor(s) (Bianchi and Cohan 1991); therefore a
means of obtaining larger quantities of conditioned
medium from inner ear cells would aid biochemical
characterization and purification efforts.
The present study tested whether conditioned
medium from conditionally immortalized otocyst cell
lines derived from the transgenic Immortomouse
(Barald et al. 1997; Bianchi and Barald 1998;
Thompson et al. 2003; Germiller et al. 2004) provides
a source of ODF-like activity. The cells used in the
present study were derived from embryonic day (E)
9.5 otocysts as previously described (Barald et al.
1997; Germiller et al. 2004). A total of 307 IMO cell
lines were cloned from these otocysts and several
have previously been characterized (Thompson et al.
2003; Germiller et al. 2004). Eight IMO cell lines
were identified as positive for hair cell markers such
as myosin VIIa, as well as supporting cell marker Hes
1 (Germiller et al. 2004). However, individual cells in
these cloned lines were found to express HC and SC
markers simultaneously in culture. These cell lines,
which are derived from the very early otocyst, appear
to represent pluripotent precursor cell lines that are
common precursors to HC and SC, and possibly SAG
neurons (Germiller et al. 2004).
In the present study, conditioned medium was
screened from five IMO cell lines that express hair
cell and supporting cell markers (Germiller et al.
2004). Four of the five lines tested were able to
promote neurite outgrowth from SAG explants. The
fifth cell line was negative for bioactivity and served as
a negative control in subsequent experiments. The
survival and neurite-promoting properties of one cell
line, IMO2B1, were then compared to the known
characteristics of ODF. IMO2B1-conditioned medi-
um was also screened for the presence of cytokines
and chemokines. Monocyte chemoattractant protein-
1 (MCP-1; originally named JE in mouse) was secret-
ed by IMO2B1 cells and importantly was subsequently
detected in mouse embryonic hair cells. Antibodies
to MCP-1 significantly decreased IMO2B1-condi-
tioned medium-induced SAG neurite outgrowth as
well as the chemoattraction of monocytes exposed to
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the IMO2B1-conditioned medium. The results of the
present study demonstrate that IMO2B1 produces
components that share many characteristics of ODF




Otocyst cell lines. Otocyst cell lines were generated
from the H2kbtsA58 transgenic mouse (Immorto-
mouse) as previously described (Barald et al. 1997;
Thompson et al. 2003; Germiller et al. 2004). Cells
from specific IMO lines were initially grown at 32-C
in chick embryo fibroblast (CEF) medium on Pri-
maria culture plates (100 mm, Falcon) to allow IMO
cells to proliferate. The proliferating cells were used
to produce a conditioned growth medium, some of
which was then diluted 1:1 (v/v) with CEF–fetal
bovine serum (FBS)–g-interferon-containing medi-
um. Other cells were grown in CEF without serum
for 4–21 days before harvesting the conditioned me-
dium. Gamma interferon, however, was replenished
every 4 days. Both serum-free and serum-containing
formulations produced conditioned medium that
promoted the survival and outgrowth of SAG neu-
rons. Control medium containing only serum
(1–10%) did not promote any outgrowth of SAG.
For the SAG cultures described in this report and
for biochemical characterization, the cell lines
were grown under serum-free conditions. Condi-
tioned media were harvested and stored at 4-C (up
to 4 months) until use. Multiple batches of condi-
tioned medium from different isolates of the same
cell lines were used for the assays in the current
study. Individual batch numbers are indicated for
each experiment.
Neuronal cultures. Explants of SAG (E5–6 chick or
E14 mouse) were prepared as described previously
(Bianchi and Cohan 1993a). Briefly, explants were
grown on poly-D-lysine-coated wells (48-well plates,
CoStar) for 24–36 h then scored for growth. SAG
explants were scored on a standard scale of 0–5
Scoring criteria for SAG explants
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(Table 1). Criteria for each score were used uniform-
ly for each ganglion examined and scored by two or
more investigators. The majority of experiments were
done with chick SAG because they are the most easily
obtained for screening bioactivity. Previous studies
had found that chick SAG respond equally well to
both chick and mouse ODF and that chick and
mouse ODF promote outgrowth similarly (Bianchi
and Cohan 1993a). To screen the activity of IMO-
conditioned medium, 200 ml of conditioned medium
was added to each ganglion. Controls were treated
with either defined medium (below) or the medi-
um used to culture IMO cells (lacking gamma-
interferon, above). Both methods produced similar
results. Human and mouse recombinant MCP-1 (R&D
Systems, Minneapolis, MN) was added at a concen-
tration of 10–1000 ng/ml diluted in defined me-
dium. Function-blocking anti-mouse MCP-1 antibody
(AF-479-NA, R&D Systems) was added to IMO2B1-
conditioned medium at concentrations of 10–300
ng/ml. Control IgG (goat, R&D Systems) was added
to the conditioned medium at concentrations of
1–200 mg/ml.
Explants of E8 chick dorsal root ganglia (DRG)
were plated on polylysine-coated wells as described
previously (Bianchi and Cohan 1993a) and treated
with human recombinant BDNF (10 ng/ml, Regen-
eron Pharmaceuticals). Mean radial outgrowth was
scored as for SAG explants (Table 1).
Dissociated SAG cells were prepared by pooling
20–30 ganglia and incubating them in 0.1% trypsin
(Sigma) in Ca2+/Mg-free phosphate-buffered saline
(PBS) for 10 min at 37-C. Ganglia were then rinsed
in Ca2+/Mg-free PBS and incubated in 0.1% trypsin
inhibitor (Sigma) for 10 min at 37-C. Ganglia were
rinsed again, then resuspended in defined culture
medium [Dulbecco’s modified Eagle’s medium
(DMEM)/F-12 supplemented with ITS+ (Collabora-
tive Research)]. Cells were dissociated with a fire-
polished pipet and plated on poly-D-lysine-coated
plates at a density of 30,000 cells per well (48-well
plates, CoStar).
To estimate cell survival, cells were fixed in 10%
neutral buffered formalin for 10 min then immuno-
labeled with an anti-neurofilament antibody (NF 150,
Chemicon). Following fixation, cells were treated
with hydrogen peroxide, rinsed in PBS, then blocked
with 1% normal goat serum. Cells were incubated
overnight in primary, anti-neurofilament antibody
(1:1000) at 4-C. The following day, cells were rinsed
carefully with PBS to prevent dislodging adherent
cells. Cells were then incubated in biotinylated
secondary antibody followed by the avidin–biotin
complex (ABC, Vector Laboratories). Sites of binding
were visualized with diaminobenzidine (DAB, Sig-
ma). The percentage of neurofilament-positive cells
was calculated from ten randomly selected fields
throughout the well.
Protein analysis
Protein array analysis. The presence of cytokines
was initially screened using TransSignal RayBio
Mouse Cytokine Antibody Array Kits (Panomics).
Two arrays are provided in each kit. For each of the
three protein array experiments conducted in the
current study, one membrane was used for control
media (unconditioned media) and the other for
IMO2B1 media that was found to promote SAG
outgrowth (batches 6.20, 9.13, 9.22). In one exper-
iment, the control membrane was sectioned so that
control media and IMO3A1 conditioned media
(negative control conditioned medium) could be
run simultaneously with the IMO2B1-conditioned
media. To assay for chemokines, IMO-conditioned
medium or control medium was incubated on the
array membranes for 1 h. The membranes were
washed and the biotinylated anti-cytokine antibody
mixture was added for 2 h at room temperature.
The membranes were then washed and incubated in
streptavidin–HRP conjugate for 1 h at room tem-
perature followed by detection with chemilumines-
cent substrate (Pierce).
Western blot analysis. IMO2B1 supernatants were
concentrated by one of two methods. Conditioned
medium (1–5 ml) was concentrated over either a 5-
or 10-kDa filter (Amicon or Centricon, respectively)
for 2–2.5 h, or 50 ml was concentrated over a
protein spin concentrator (Amicon; 10-kDa cutoff)
for 30 min. These concentrated samples and positive
controls, recombinant human MCP-1 and recombi-
nant mouse MCP-1 (R&D Systems), were run on 10–
20% Tris tricine gels (BioRad) for 70 min at 100 V
followed by blot transfer onto a polyvinylidene
difluoride membrane (BioRad) for 1 h at 100 V.
The membrane was blocked in bovine serum albu-
min, then rinsed in Tris-buffered saline (TBS) with
0.05% Tween (TTBS) and incubated in primary
antibody (anti-mouse MCP-1/JE, R&D Systems, AE
479 NA) overnight at 4-C. The membranes were
rinsed in TTBS and then incubated in secondary
antibody (peroxidase-conjugated rabbit anti-goat
antibody, Jackson ImmunoResearch, 1:10,000) at
4-C overnight. The membranes were then rinsed in
TTBS and TBS then exposed to the Westpico
chemiluminescent substrate (Pierce) and subse-
quently exposed to film (Pierce). Control blots were
processed simultaneously as above, excluding the
primary antibody.
Immunocytochemistry. Cultured E14 mouse inner
ear cells were double-labeled for MCP-1 and the
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hair cell marker myosin VI. Dissociated embryonic
day 14 (E14) mouse inner ears were cultured as
described previously (Bianchi et al. 2002). In this
preparation inner ear cells reaggregate into distinct
patterns within 24 h in vitro. One aggregate type, the
dome, is composed of both hair cells and supporting
cells as identified with hair cell and supporting cell
markers (Bianchi et al. 2002). Hair cells are gener-
ally located more centrally, with supporting cells sur-
rounding the hair cells. Briefly, inner ear cells were
fixed in formalin, rinsed in PBS, blocked in
normal serum and incubated overnight in primary
antibodies (anti-myosin VI, 1:50, T. Hasson, UCSD;
anti-MCP-1, 1:10, anti-TNF alpha 1:10, anti-RANTES
1:10; R&D Systems,). The following day, cultures
were rinsed, incubated in fluorescent secondary
antibodies (Texas Red, fluorescein, 1:50, Jackson
ImmunoResearch) for 2 h then viewed with a Zeiss
LSM-5 confocal microscope.
Monocyte chemotactic assay. To confirm the chemo-
tactic activity of the MCP-1 protein and the function-
blocking abilities of the anti-MCP-1 antibody used in
the SAG assays, a classic monocyte chemotactic assay
was used. The mononuclear cells were isolated from
whole blood (50 ml) drawn from one of the inves-
tigators (NWL) under protocols approved by the
University of Michigan Institutional Review Board.
Whole blood was mixed 1:1 with normal saline
(Merck). Ficoll-Hypaque (FH, 15 ml, Beckman-Coul-
ter) was layered into each of six 50-ml conical
polypropylene tubes (Corning) and the blood/saline
mixture (15 ml) was carefully layered over the FH.
Tubes were centrifuged in a Beckman refrigerated
centrifuge at 400  g for 30 min at 20-C. The plasma
layer was removed by careful pipetting. The mono-
nuclear layer (buffy coat) was placed in separate
tubes (25 ml) and the total volume in each tube was
brought to 50 ml with PBS. The tubes were centri-
fuged at 900  g for 10 min at 4-C, the superna-
tant was discarded and the pellet resuspended in
50 ml of F-12 medium (Invitrogen). Centrifugation
and washes were repeated three times. The final
pellet was resuspended in 5 ml of F-12 medium and
50 ml was used for trypan blue exclusion and cell
counting. The remaining cells were resuspended in a
total of 6.66 ml of F-12 to bring the total to 3  106
viable cells/ml.
The monocyte samples to be tested for chemotaxis
were pipetted at a volume of 162 ml per well in at least
triplicate wells in a 12-well chemotaxis chamber (Ann
Arbor Plastics Co.) An 8-mm pore-size polycarbonate
filter (polyvinylpyrrolidone-free, Nucleopore Corp.)
was placed over the wells, and the flexible gasket
secured with the top chamber by screws. The
monocyte-containing blood cell suspension (100 ml)
was placed into the top wells and the chambers
placed in a 37-C humidified CO2 incubator for 1 h.
The top chamber and remaining cells were then were
removed, the upper side of the membrane scraped
with a cell scraper to remove nonmigratory cells, and
the membrane was hung to dry at room temperature
for 1 h. At the end of that time, the membranes were
fixed in MeOH for 10 min, stained with 2% toluidine
blue, and then counterstained with hematoxylin and
eosin. Counts of the monocytes among the cells that
had migrated to the underside of the membrane
were taken from ten random fields using an Olympus
microscope in bright field at 1000 magnification.
Chemotactic activity was expressed as the mean
number of migrated monocytes per total of ten fields
in n = 3–7 replicates of each group tested for cytokine
activity, less the background number of cells that
migrated through the filter in medium-only controls.
Background was calculated from the two control
media (F-12, the base medium in CEF or in Opti-
pro, the serum-free medium; Invitrogen). The re-
agents tested in this experiment were used at the
concentrations recommended by the manufacturer
(R&D Systems). The assay included recombinant
human MCP-1/CCL2 (20 ng/ml, R&D Systems, 279-
MC, lot no. NS023021); MCP-1 preneutralized with
anti-mouse MCP-1/JE antibody (5 mg/ml, R&D
Systems, AF-479-NA, lot no. 192403). IMO2B1-condi-
tioned medium that had previously been shown to be
positive in the SAG outgrowth assay was also tested in
the chemotaxis assays (both with and without the
addition of anti-MCP-1 antibody). Control wells of
undiluted F-12 (Invitrogen, n = 4) medium alone or
Optipro medium (Invitrogen, n = 3) were used to
establish a background level of monocyte chemotax-
is. The average number of monocytes in control
conditions (58, n = 7) was subtracted from each
experimental group prior to graphing the data.
Statistical analysis. Student’s t tests were used to
make comparisons between groups. P values of less
than 0.05 were used as the level of statistical
significance.
RESULTS
Inner ear cell lines secrete neurite
outgrowth—promoting factors
To screen for bioactive factors in conditioned
medium from IMO cell lines, SAG explants from
E5 chick embryos were plated on poly-D-lysine-
coated dishes. The explants were then treated with
200 ml of serum-free IMO-conditioned medium or
control medium that was not exposed to IMO cells.
After 24 h in culture, the explants were scored using
a scale of 1–5 (Table 1). Individual explants treated
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with IMO2D2, IMO1G1, IMO3C3, or IMO2B1-condi-
tioned medium produced outgrowth with scores
ranging from 2.0 to 5.0; with mean scores of 2.5–3.4
(n = 23–25 SAG per condition; Fig. 1A). In contrast,
explants grown in IMO3A1 or control (uncondi-
tioned) medium produced outgrowth of less than
0.5 (n = 12; Fig. 1B). These results demonstrated that
conditioned medium from four of the five IMO cell
lines tested produced outgrowth significantly greater
than control medium (p G 0.01). The IMO2B1-
conditioned medium (batches 6.20, 9.22) consistent-
ly produced the most extensive outgrowth (mean
score 3.4). The extent and morphology of outgrowth
was similar to that previously observed with chick-
and mouse-derived ODF (Bianchi and Cohan 1993a).
Thus, IMO2B1-conditioned medium was selected for
subsequent analysis.
IMO2B1 cells produce factors that influence SAG
neuron survival. To calculate the neuronal survival ob-
tained with conditioned medium from the IMO2B1
cell line, dissociated E5 chick SAG neurons were
assayed. Survival of SAG in the presence of IMO2B1-
conditioned medium (batch 1.90) was estimated by
counting the number of neurofilament positive cells
after 24 h in vitro (Fig. 1C). In the presence of this
IMO2B1-conditioned medium, 52% of the SAG
neurons were neurofilament positive (n = 12 wells).
This was significantly greater than control cultures in
which only 13% of the cells were neurofilament
positive (p G 0.01, n = 6 wells; Fig. 2). The survival
obtained with IMO2B1-conditioned medium was
similar to that obtained previously with ODF (Bianchi
and Cohan 1993a). Together, the bioassay experi-
ments found ODF-like activity in IMO2B1-condi-
tioned medium in both neurite-promoting and
survival assays.
FIG. 1. (A) E5 chick SAG grown in the presence of IMO2B1-
conditioned medium exhibits extensive neurite outgrowth (explant
score = 4, batch 9.22). (B) E5 chick SAG grown in control (uncon-
ditioned) medium does not produce outgrowth (explant score = 0).
Magnification, 100. (C) Dissociated E6 chick SAG neurons grown in

















FIG. 2. Survival of dissociated E5 chick SAG neurons in IMO2B1
(batch 1.90) was significantly higher than SAG grown in control
medium. (p G 0.01; TSE).
FIG. 3. Protein array analysis of (A) IMO2B1-conditioned media
and (B) control medium. An array was section in order to test
unconditioned medium and negative control IMO3A1 at the same
time (B). Control medium that was not exposed to IMO cells (top, B)
and IMO3A1-conditioned medium that failed to promote neurite
outgrowth from chick SAG (batch 11.23; bottom, B) only detected
the manufacturer’s positive controls (biotinylated HRP conjugate, +)
and low levels of gamma interferon (G). All other cytokines were
below the level of detection in these media. In contrast, soluble TNF
receptor 1 (T), gamma interferon (G), MCP-1 (M), and low levels of
RANTES were detected in IMO2B1-conditioned medium shown to
promote neurite outgrowth (A, batch 9.13). (– Indicates negative
controls, + positive controls).
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Chemokines are present in IMO2B1-conditioned
medium and inner ear cells
Chemokines are detected by protein array analysis.
IMO2B1-conditioned medium was screened for the
presence of cytokines/chemokines using the TranSig-
nal RayBio antibody array (Panomics). IMO3A1,
which did not promote SAG outgrowth, was used as a
control (batch 11.23; Fig. 3B, bottom). MCP-1, which
can be detected as low as 5 pg/ml on the array, was
prominently expressed in three independent trials
with different batches of IMO2B1 (batches 6.20, 9.13,
9.22). MCP-1 was consistently the most highly
expressed protein present on the arrays incubated
with IMO2B1-conditioned medium. Very low levels of
RANTES were faintly detected in all three batches of
IMO2B1, although this low level of expression was not
always apparent in the photomicrographs. RANTES
can be detected at a level of 50 pg/ml on the array.
Low levels of TNF alpha were detected in two out of
the three trials (batches 6.20, 9.22), whereas soluble
TNF receptor 1 (TNFR1) was detected in one of the
trials (batch 9.13, Fig. 3A). Gamma interferon, which
is present in the medium added to IMO cultures, was
also detected in all IMO2B1 batches as expected
since the cells are grown in this medium to ensure
proliferation (Fig. 3A). Gamma interferon also
appeared to be more highly expressed than in
control medium (below). The g-interferon used in
this study (Chemicon) is a recombinant mouse
interferon expressed in E. coli and subsequently
affinity purified by the manufacturer and tested for
impurities and the absence of other contaminating
cytokines. No such contaminants were present in the
g-interferon. The other cytokines present on the blot
were below the level of detection in IMO2B1-condi-
tioned medium. These included G-CSF, GM-CSF, IL-
2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12, IL-12p70,
IL-13, IL-17, MCP-5, CSF, TPO, and VEGF.
In contrast to IMO2B1-conditioned medium,
IMO3A1-conditioned (batch 11.23) medium did not
contain detectable levels of MCP-1, RANTES, TNF
alpha, sTNFR1, or any of the other cytokines present
on the array (Fig. 3B, bottom; note that IL-4 and IL-5
were not tested in this experiment due to the
sectioning of the array blot). Furthermore, control
media with 4% serum (Fig. 3B, top) or without 4%
serum (not shown) were also negative for the cyto-
kines tested.
MCP-1 is expressed in inner ear cells. To explore the
potential biological role of identified chemokines in
the developing inner ear, immunocytochemistry was
performed. MCP-1, RANTES, and TNF alpha were
examined in paraffin-embedded tissues of embryonic
and adult mouse inner ear tissues. The MCP-1,
RANTES, and TNF alpha antibodies used in this study
were not indicated for use in paraffin-embedded
tissues by the manufacturer and attempts at examin-
ing these proteins in paraffin-embedded inner ear
tissues resulted in inconclusive immunoreactivity in
both the embryonic and adult mouse inner ear tissues.
Therefore, primary cultures of dissociated E14 mouse
inner cell cells were used. The E14 mouse inner ear
FIG. 4. Immunofluorescence (green) representing the secondary
antibody binding to the hair cell marker myosin VI was detected in
hair cells of dissociated E14 mouse inner ear cultures. The dissociated
cells form aggregates of hair cells and supporting cells. MCP-1 was
also prominently expressed in hair cells (red), as well as in some
unidentified cells surrounding the aggregate. Supporting cells within
the aggregate were negative for MCP-1. The third panel demonstrates
the areas where myosin VI and MCP-1 immunofluorescence overlaps
(yellow). These results demonstrate that hair cells express MCP-1.
Magnification, 630.
FIG. 5. Western blot analysis demonstrated MCP-1-like protein in
active IMO2B1-conditioned medium when concentrated by filtra-
tion column chromatography. Lane 1: recombinant mouse MCP-1
(100 ng/ml; R&D Systems); lane 2: IMO2B1-conditioned medium of
(batch 4.22); lane 3: IMO2B1-conditioned medium (batch 4.25);
lane 4: IMO2B1 (batch 4.28); lane 5: IMO2B1-conditioned medium
(batch 5.11); lane 6: recombinant mouse MCP-1 (200 ng/ml, R&D
Systems); lane 7: IMO2B1-conditioned medium (batch 4.22 con-
centrated); lane 8: IMO2B1-conditioned medium (batch 4.25,
concentrated); lane 9: IMO2B1-conditioned medium (batch 4.28
concentrated); lane 10: IMO2B1-conditioned medium (batch 5.11
concentrated). Molecular weight standards (kDa) are indicated at the
left.
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produces ODF bioactivity and our established assay
enables easy identification of embryonic hair cells and
supporting cells at this stage of development in
cultured inner ear Bdomes^ (Bianchi et al. 2002).
RANTES and TNF alpha were below the level of
detection in all samples examined, including samples
that were double labeled with the hair cell marker
myosin VI. In contrast, MCP-1 was highly expressed
in aggregates of hair cells and supporting cells.
Cultures that were double-labeled with a hair-cell-
specific marker (anti-myosin VI antibody) and MCP-1
demonstrated that MCP-1 was prominently expressed
in embryonic hair cells (Fig. 4). MCP-1 immu-
noreactivity was not detected in the cytokeratin-
expressing supporting cells that surround the hair
cells (Bianchi et al. 2002). MCP-1 reactivity was
detected in some of the cells surrounding the hair
cell–supporting cell aggregates (Fig. 4). Because these
cells do not express myosin VI or cytokeratin (the
supporting cell marker), they remain unidentified.
Western blot analysis (Fig. 5) confirmed that the
antibody (R&D Systems) detected MCP-1-like protein
in both purified samples of mouse (Fig. 5) and
human (not shown) MCP-1 (100–200 ng/ml, R&D
Systems, 279-MC) as well as in the bioactive IMO2B1
supernatants (batches 2.05, 4.22, 4.25, 4.28, 5.11,
9.13). IMO2B1-conditioned medium was concentrat-
ed using molecular weight cutoff filters. When
molecular weight filters with 1–5 ml of conditioned
medium were used, only a faint band was detected at
a molecular weight range that was slightly higher
than that of the purified MCP-1. In contrast, when
the 50 ml of conditioned medium were concentrated
over a 10-kDa filter, prominent bands at the same size
as purified MCP-1 were detected. In all samples,
including negative controls lacking primary antibody,
several higher molecular weight bands were also
detected between approximately 50 and 100 kDa.
These were likely due to nonspecific binding of the
secondary antibody. However, because the IMO2B1-
conditioned medium is a complex mixture of pro-
teins, the possibility that the primary antibody also
detected higher molecular weight proteins or protein
complexes cannot be ruled out.
Blocking MCP-1 activity reduces SAG outgrowth. To
examine whether MCP-1 was a neurite-promoting
component in the IMO2B1-conditioned medium,
anti-MCP-1 function-blocking antibody (10–300 ng/
ml, R&D Systems) was added to IMO2B1-conditioned
medium. In the first series of experiments, outgrowth
of E5 chick SAG explants was significantly inhibited
when the IMO2B1-conditioned medium (batch 9.22)
was treated with 150 ng/ml of anti-MCP-1 antibody
(mean score 0.6, n = 5, SE 0.3, p G 0.01; Figs. 6 and 7).
The limited amount of growth observed was similar
to that observed in controls grown in unconditioned,
defined culture medium (mean score 0.5, n = 9).
Addition of 75 ng/ml of anti-MCP-1 antibody pro-
duced similar reductions in growth (mean 0.5, n = 2).
Concentrations of this function-blocking antibody at
19 or 38 ng/ml decreased, but did not entirely
eliminate, outgrowth (mean outgrowth 1.8 and 1.2,
respectively, n = 2 each). At higher concentrations
(300 ng/ml), the MCP-1 antibody caused the SAG
explants to lift from the surface of the dish and
appear flat and thin (n = 2).
The effective concentration of anti-MCP-1 anti-
body varied with each preparation of IMO2B1-
conditioned medium, likely reflecting differences in
the total amount of MCP-1 activity in each batch. For
example, in a second series of experiments, 75 ng/ml
of the anti-MCP-1 antibody led to SAG explants
lifting from the surface of the culture well (IMO2B1
batch 4.29; n = 3). Controls treated with IMO2B1
(batch 1.90) and IgG at concentrations ranging from
1 to 200 mg/ml did not inhibit outgrowth of SAG
(mean score 3.4; n = 5).
To test for nonspecific general neurotoxic effects























FIG. 6. E5 chick SAG treated with IMO2B1 produced neurite
outgrowth (mean 2.6, SE 0.6, n = 5, batch 9.22). Addition of 150 ng/
ml of anti-MCP-1 antibody to the IMO2B1 medium decreased
outgrowth of SAG significantly (mean 0.6, SE 0.3, n = 5, p G 0.01,
batch 9.22).
FIG. 7. (A) IMO2B1-conditioned medium promoted neurite out-
growth of E5 chick SAG (batch 9.22; explant score = 4). (B) Addition
of anti-MCP-1 antibody (150 ng/ml) decreased E5 chick SAG
outgrowth (explant score = 1.5). The photo shows the area of
maximal outgrowth. Magnification, 100 (A), 200 (B).
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SAG outgrowth, E8 DRG explants were grown in the
presence of BDNF (10 ng/ml), a concentration that
promotes DRG outgrowth, and anti-MCP-1 antibody
was added. DRG explants continued to grow in the
presence of BDNF with 75 ng/ml of anti-MCP-1
antibody (mean score 3.3, n = 3, SE 0.8) or BDNF
with 150 ng/ml of anti-MCP-1 antibody (mean 3.5,
n = 4, SE 3).
MCP-1 alone is insufficient to promote SAG outgrowth.
To test the role of MCP-1 in SAG outgrowth further,
MCP-1 (human or mouse recombinant, R&D Sys-
tems) was added to cultures of E5 chick or E13
mouse SAG grown in control medium. However, no
growth was noted when MCP-1 was added at concen-
trations ranging from 10 to 1000 ng/ml in any of
these assays (E5 chick, n = 14, human recombinant
MCP-1; E13 mouse recombinant MCP-1, n = 9,
human MCP-1; E5 chick, n = 25, mouse recombinant
MCP-1; E14 mouse, n = 4, mouse recombinant MCP-
1). This suggested that the MCP-1 was inactive or that
MCP-1 may require additional factors to promote
SAG outgrowth.
MCP-1 and IMO2B1-conditioned medium demonstrate
chemotactic properties in a monocyte chemotaxis assay.
To confirm that the MCP-1 used in the SAG assays
retained bioactivity and that the function-blocking
antibody both recognized MCP-1 and inhibited
MCP-1 chemotactic activity, a standard, classic mono-
cyte chemotactic assay was used. This assay also
allowed testing of the chemotactic properties of
IMO2B1-conditioned medium. In this assay, the
number of monocytes that migrate through a filter
is determined in both experimental and control
wells. The number of cells in the control wells is
designated as Bbackground^ and the average num-
ber of these cells is subtracted from the total
number of cells that migrate in the experimental
wells (background mean in these experiments was
58 cells, n = 7). In the presence of MCP-1 protein,
monocytes migrated through a chemotactic chamber
filter (8-mm pore) as expected (Fig. 8; mean 299, SE
40, n = 4), confirming that the MCP-1 was active. The
anti-MCP-1 antibody reduced the migration of the
monocytes significantly (Fig. 8; mean 46, SE 31, n = 3,
p G 0.05, Fig. 7) demonstrating that it too was
bioactive and able to block MCP-1 chemotactic
activity. IMO2B1-conditioned medium (batch 2.05)
was also tested in these assays and demonstrated the
ability to induce migration of monocytes at a level
greater than background (Fig. 8; mean 58, SE 14, n =
7). The anti-MCP-1 antibody also significantly
inhibited migration of the monocytes treated with
IMO2B1 (batch 2.05), further demonstrating the
presence of MCP-1-like activity in the IMO2B1-
conditioned medium (Fig. 8; mean 11, SE 8, n = 6,
p G 0.05, Fig. 7). The IMO2B1-conditioned medium
likely contains much lower levels of MCP-1 than the
20 ng/ml of purified MCP-1 used in these assays,
which would account for the more modest chemo-
tactic effect in wells treated with IMO2B1. However, it
is important to note that the IMO2B1 has a statisti-






















FIG. 8. Monocyte migration was measured using a classic
chemotactic assay. The number of migrating cells is depicted
minus the background number of cells migrating in control
conditions (mean 58 cells, SE 19, n = 7). In the presence of MCP-
1 (20 ng/ml), monocytes migrated to the side of the chamber
containing the protein (mean 299, SE, 40, n = 4). Addition of the
function-blocking anti-MCP-1 antibody reduced the migration of the
monocytes significantly (mean 46, SE 31, n = 3, p G 0.01). IMO2B1
alone also induced the migration of monocytes above background
levels (mean 58, SE 14, n = 7, batch 2.05) and the function-blocking
antibody decreased this migration significantly (mean 11, SE 8, n =

























FIG. 9. IMO2B1-conditioned medium produced outgrowth from
E5 chick SAG (IMO2B1 batch 9.13, mean 3.4, SE 0.35, n = 7).
When anti-MCP-1 function-blocking antibody was added at a
concentration of 10 or 25 ng/ml (n = 14 total) the amount of
outgrowth was reduced significantly (mean 1.97, SE 0.42, n = 14,
p G 0.01). Supplementing the anti-MCP-1-treated IMO2B1-condi-
tioned medium with MCP-1 (Badd back^, 20 ng/ml) led to a
statistically significant increase in SAG neurite outgrowth (mean
3.72, SE 0.31, n = 11, p G 0.01) above that observed with anti-MCP-
1 only, indicating a direct role for MCP-1 in promoting SAG
outgrowth. No further increase was noted when 200 ng/ml of
MCP-1 (mean 2.7, SE 0.42, n = 5; p 9 0.01) was added to the
antibody-treated cultures.
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that this migration can be blocked specifically by the
anti-MCP-1 antibody.
MCP-1 as a cofactor for neurite outgrowth. The failure
of MCP-1 alone to induce neurite outgrowth from
SAG may have been because MCP-1 is only one of
the neurite-outgrowth-promoting proteins in the
IMO2B1-conditioned medium. To test for the inter-
action of MCP-1 with these putative, unidentified
proteins, MCP-1 was added to cultures of E5 chick
SAG treated with both IMO2B1-conditioned medium
and anti-MCP-1 antibody. Anti-MCP-1 was added at a
concentration of 10 or 25 ng/ml. At these concen-
trations, anti-MCP-1 reduced, but did not eliminate
all outgrowth, in the batches of IMO2B1-conditioned
medium assayed (Fig. 9, batches 4.29 and 9.13, mean
1.97, SE 0.42, n = 14). MCP-1 was then added to
antibody-treated conditioned medium at a concen-
tration of 20 ng/ml (n = 11) or 200 ng/ml (n = 5).
Under these conditions, 20 ng/ml MCP-1 was able to
increase SAG outgrowth significantly above that
observed in the presence of the IMO2B1-conditioned
medium and anti-MCP-1 alone (batches 4.29 and
9.13, mean 3.7, SE 0.31, n = 11; p G 0.05; Fig. 9),
whereas 200 ng/ml of MCP-1 did not increase growth
in this assay (batch 9.13, mean 2.7, SE 0.42, n = 5, p 9
0.05). The amount of neurite outgrowth from SAG
treated with 20 ng/ml of MCP-1 was similar to that
observed with IMO2B1-conditioned medium alone
(n = 6, Fig. 9). It is not clear why 200 ng/ml of MCP-1
did not promote growth further. It is possible that
the decrease in growth reflects the typical dose–
response curve seen with MCP-1 and other growth
factors at higher concentrations. Thus, MCP-1 (20
ng/ml) appears to be at least one of the active
components of the IMO2B1-conditioned medium
that is capable of interacting with other molecules
to promote SAG outgrowth.
DISCUSSION
Sources of inner ear growth factors. Previous studies have
demonstrated that the otocyst is a source of survival
and neurite-promoting activity for early stage SAG
(Ard and Morest 1984; Ard et al. 1985; Lefebvre et al.
1990; Bianchi and Cohan 1991, 1993a). However, the
growth factor(s) required for initial outgrowth of
SAG has not yet been fully characterized. Identifying
the molecules that are active at early stages of SAG
development is challenging due to the small size of
the otocyst and the minute quantities of conditioned
medium that are generated at any given time. For
example, in order to produce ODF, eight E4–5 chick
otocysts are cultured in 250 ml of culture medium for
3 days. Due to the limited quantities of ODF
generated by the otocyst, another source of ODF-like
activity was needed.
Immortalized inner ear cell lines. The development of
conditionally immortalized otocyst cells lines provid-
ed a source of unlimited amounts of conditioned
medium and a potential source of ODF-like activity.
In the present study, four IMO cell lines were found
to promote SAG neurite outgrowth. A fifth cell line,
IMO3A1, did not promote outgrowth of SAG.
Of the positive cell lines identified, the IMO2B1
cell line has been characterized most extensively
(Thompson et al. 2003; Germiller et al. 2004).
IMO2B1-conditioned medium promoted outgrowth
of SAG explants and also promoted outgrowth and
survival of dissociated SAG neurons similar to that
observed with chick or mouse ODF. It is important to
note that the cells of the IMO2B1 line maintain many
of the characteristics of developing inner ear sensory
epithelia (Gerlach et al. 2000; Thompson et al. 2003;
Germiller et al. 2004; Barald and Kelley 2004). It is
believed that the IMO2B1 cell line represents a
multipotential precursor population that can give
rise either to HC-like or SC-like cells under the
influence of specific culture conditions (Germiller
et al. 2004). The IMO2B1 cell line therefore appears
to be an excellent source of material for identifying
the neurite-promoting factor(s) released by cells of
the early stage inner ear. As in all cases of cell-line-
derived materials, any molecular components identi-
fied in the cell lines have to be confirmed in the
developing inner ear. So far, the cell lines have
proven to be good predictors of results in the embryo
(Thompson et al. 2003; Germiller et al. 2004).
Chemokines in inner ear cells. IMO2B1-conditioned
medium was screened for cytokines/chemokines
using a specific protein array. Cytokines/chemokines
had not previously been investigated for SAG out-
growth-promoting activity. Chemokines consist of
over 40 members that are classified into four distinct
families based on the location of the cysteine residues
(Mennicken et al. 1999). Each chemokine binds to
one or more specific G-protein-coupled receptor.
Chemokines have traditionally been associated with
inflammatory responses, but recently have been
associated with more diverse roles including regulat-
ing the migration and survival of neurons (Menniken
et al. 1999; Chalasani et al. 2003a,b; Belmadani et al.
2005). For example, IL-8 promotes survival of hippo-
campal neurons (Araujo and Cotman 1993) and
stromal-cell-derived factor 1 (SDF-1) promotes sur-
vival of retinal ganglion cells, even in the absence of
neurotrophins (Chalasani et al. 2003b). SDF-1 also
promotes the survival of sympathetic neurons and the
receptor for SDF-1 is present in a number of neural
populations (Chalasani et al. 2003b). RANTES has
been found to influence the migration and differen-
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tiation of DRG neurons (Bolin et al. 1998) and MCP-
1 has been detected in the developing cerebellum
where it has been suggested that it may regulate
axonal outgrowth (Meng et al. 1999). Thus, several
chemokine family members are implicated in regu-
lating normal aspects of neural development.
Of the 22 cytokines/chemokines present in the
commercial protein array examined in the present
study, only 4 were detected in the IMO2B1-condi-
tioned medium. The MCP-1 protein was consistently
the most highly expressed in all batches of IMO2B1-
conditioned medium tested. MCP-1 is a member of
the CC or beta family of chemokines and binds to the
CCR2 and CCR4 chemokine receptors. In the
present study, MCP-1 was also found to be promi-
nently expressed in E14 mouse hair cells. Preliminary
results suggest that one receptor, CCR2 is present in
embryonic chick SAG neurons (unpublished obser-
vations); however, whether other chemokine recep-
tors are present or differentially expressed has not yet
been determined.
Chemokines as neurite-promoting factors. To test
whether MCP-1 influenced SAG outgrowth, MCP-1
protein alone was added to cultures of chick or
mouse SAG explants. However, no outgrowth was
observed, at least at the concentrations evaluated. In
contrast, addition of function-blocking antibody to
the IMO2B1-conditioned medium decreased SAG
outgrowth in a dose-dependent manner (10–150
ng/ml). The bioactivities of the MCP-1 and the anti-
MCP-1 antibody used in the assays were confirmed in
a monocyte chemotaxis assay, indicating that the
failure of MCP-1 to promote outgrowth was not due
to inactive protein. The specificity of the antibody
used in these studies was also confirmed by Western
blot analysis. The antibody recognized purified
mouse and human MCP-1 and detected an MCP-1-
like molecule in the bioactive IMO2B1-conditioned
media. The intensity of the band detected in the
IMO2B1-conditioned medium was greater when 50
ml IMO2B1-conditioned medium was concentrated
over a 10-kDa filter compared to 1–5 ml being con-
centrated over 5- or 10-kDa filters. This is not
surprising as growth factors are typically produced
in the picogram range making it difficult to detect
such proteins, even following concentration of the
supernatants. The protein array that first identified
MCP-1 in the IMO2B1-conditioned medium was able
to detect MCP-1 as low as 5 pg/ml, whereas the
antibody used in the Western blotting experiments
could only detect MCP-1 as low as 5 ng/ml under the
reducing conditions. Because the IMO2B1-condi-
tioned medium is a complex mixture of proteins
and protein complexes, the possibility that additional
proteins are detected by the function-blocking anti-
body cannot be entirely ruled out. However, consid-
ering the above data as well as the observation that the
antibody specifically blocked chemotactic activity of
both purified MCP-1 and IMO2B1 in the monocyte
assay, it seems unlikely that the anti-MCP-1-antibody
blocked another protein in the IMO2B1-conditioned
medium. It is also important to note that addition of
other function-blocking antibodies to IMO2B1-condi-
tioned medium including anti-TNF alpha and anti-
BDNF did not reduce the amount of outgrowth
(unpublished observations).
Further support for the hypothesis that MCP-1 is
a cofactor that promotes SAG outgrowth was
obtained in experiments that demonstrated the
addition of MCP-1 (20 ng/ml) to IMO2B1-condi-
tioned medium treated with the function-blocking
anti-MCP-1 antibody resulted in a medium that
allowed SAG neurites to extend to lengths similar
to SAG treated with only IMO2B1-conditioned
medium. Thus, addition of MCP-1 Brescued^ the
antibody-treated SAG, allowing for neurite out-
growth to occur. It therefore appears that MCP-1
can produce outgrowth when SAG are provided with
additional, as yet unidentified components found in
the IMO2B1-conditioned medium. Addition of
higher concentrations of MCP-1 (200 ng/ml) did
not produce outgrowth greater than control levels.
This may be a reflection of the sample size or a
result of reaching a saturating level of MCP-1. In
chemotactic assays, the most effective concentrations
of the MCP-1 used in these studies ranged between
4–20 ng/ml (R&D Systems).
Other chemokines such as SDF-1 have failed to
directly attract retinal or DRG axons but appear to
influence the activity of other molecules, including
inhibitory proteins (Chalasani et al. 2003a). Further
studies are under way to determine which other
components(s) are present in the IMO-generated
ODF, which are active at this stage of SAG outgrowth,
and how they may interact with MCP-1. Neurotrophins
are known to be required for survival and growth of
later developmental-stage inner ear afferent neurons
(Fritzsch et al. 1997; Tessarollo et al. 2004), and FGFs
may potentiate some of the effects of neurotrophins
(Hossain et al. 1997; Brumwell et al. 2000). It is not
known whether MCP-1 interacts with neurotrophins
or FGFs at earlier stages. Recent studies revealed that
neurotrophins did not enhance the survival of retinal
ganglion cells in the presence of the chemokine SDF-
1; nor did SDF-1 influence trk expression (Chalasani
et al. 2003b). Thus, other molecules may interact
with MCP-1 during the stage of initial SAG out-
growth. When IMO2B1-conditioned medium was run
on polyacrylamide gels, a complex protein mixture
was observed. Over 30 distinct bands were detected
(Bianchi and Richards, unpublished observations;
Molea and Barald, unpublished observations). Thus,
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there are a number of as yet unidentified potential
proteins that may interact with MCP-1 to promote
SAG outgrowth.
Several cytokines and chemokines have been
observed in specific regions of the mature inner
ear, particularly the lateral wall, where they are
hypothesized to be involved in mediating an inflam-
matory response following infection or trauma to the
inner ear (Yoshida et al. 1999; Ichimiya et al. 2000;
Adams 2002). These results suggest multiple roles for
MCP-1 in the inner ear, depending on its cellular
localization and time of expression.
In summary, the present study reports the initial
characterization of the first abundant source of ODF-
like activity and the first observation of the chemokine
MCP-1 as an inner-ear-derived, neurite-promoting
molecule. Overall, the results of these experiments
demonstrate the utility of the IMO cell lines in
identifying candidate proteins that regulate inner ear
development. The abundant quantities of condi-
tioned medium that can be generated from the IMO
cell lines will allow for both purification efforts to
identify other biologically active proteins involved in
outgrowth and survival of early-stage SAG, as well as
the identification of specific proteins involved in other
aspects of inner ear development.
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